Biocare Medical and Hamamatsu Partner on Integrated Spatial Biology Platform

Nov 6, 2025
Biocare Medical and Hamamatsu have announced a strategic collaboration to deliver an integrated spatial biology solution combining staining and imaging systems for research institutions and biopharma companies.

Biocare Medical and Hamamatsu have announced a strategic collaboration to offer an integrated spatial biology workflow, according to a press release. The partnership combines Biocare’s ONCORE Pro X automated staining instrument with Hamamatsu’s MoxiePlex multi-spectral imaging system.

The co-exclusive offering provides an end-to-end solution for multiplex immunofluorescence and immunohistochemistry staining through to high-resolution digital imaging. It is designed for use by pharmaceutical and biotech companies, academic research institutions, and contract research organizations.

Hamamatsu’s MoxiePlex system is already being used in research-use-only projects with cancer centers and CROs. The new agreement expands Hamamatsu’s reach in immunohistochemistry and spatial biology by integrating its imaging technology with Biocare’s staining platforms and global distribution network.

The collaboration aims to support more efficient spatial biology and translational research workflows, offering a reproducible and scalable approach for multiplex immunofluorescence applications.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.